Impact of obesity treatment on gastroesophageal reflux disease

World Journal of Gastroenterology

Volumn 22, Issue 4, 2016, Pages 1627-1638

  Khan, Abraham ^a   Kim, Aram ^a   Sanossian, Cassandra ^a   Francois, Fritz ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Fundoplication; Gastric banding; Gastric bypass; Gastroesophageal reflux disease; Obesity; Sleeve gastrectomy

Indexed keywords

ANTACID AGENT; HISTAMINE H2 RECEPTOR ANTAGONIST; PROTON PUMP INHIBITOR; GASTROINTESTINAL AGENT;

CONSERVATIVE TREATMENT; ENDOSCOPIC SURGERY; GASTRIC BANDING; GASTRIC BYPASS SURGERY; GASTROESOPHAGEAL REFLUX; HUMAN; LIFESTYLE MODIFICATION; OBESITY; PATHOPHYSIOLOGY; REVIEW; SLEEVE GASTRECTOMY; STOMACH FUNDOPLICATION; TREATMENT OUTCOME; ADVERSE EFFECTS; BARIATRIC SURGERY; COMPLICATION; PATIENT SELECTION; RISK ASSESSMENT; RISK FACTOR; WEIGHT REDUCTION;

BARIATRIC SURGERY; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL AGENTS; HUMANS; OBESITY; PATIENT SELECTION; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 85006468149     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/WJG.V22.I4.1627     Document Type: Review

References (117)

1. Katz PO, Gerson LB, Vela MF. Guidelines for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol 2013; 108: 308-328; quiz 329 [PMID: 23419381 DOI: 10.1038/ajg.2012.444]
2. Song JH, Chung SJ, Lee JH, Kim YH, Chang DK, Son HJ, Kim JJ, Rhee JC, Rhee PL. Relationship between gastroesophageal reflux symptoms and dietary factors in Korea. J Neurogastroenterol Motil 2011; 17: 54-60 [PMID: 21369492 DOI: 10.5056/jnm.2011.17.1.54]
3. Jacobson BC, Somers SC, Fuchs CS, Kelly CP, Camargo CA. Body-mass index and symptoms of gastroesophageal reflux in women. N Engl J Med 2006; 354: 2340-2348 [PMID: 16738270 DOI: 10.1056/NEJMoa054391]
4. Wilson LJ, Ma W, Hirschowitz BI. Association of obesity with hiatal hernia and esophagitis. Am J Gastroenterol 1999; 94: 2840-2844 [PMID: 10520831 DOI: 10.1111/j.1572-0241.1999.01426.x]
5. Pandolfino JE, El-Serag HB, Zhang Q, Shah N, Ghosh SK, Kahrilas PJ. Obesity: a challenge to esophagogastric junction integrity. Gastroenterology 2006; 130: 639-649 [PMID: 16530504 DOI: 10.1053/j.gastro.2005.12.016]
6. Roman S, Pandolfino JE. Environmental - lifestyle related factors. Best Pract Res Clin Gastroenterol 2010; 24: 847-859 [PMID: 21126698 DOI: 10.1016/j.bpg.2010.09.010]
7. Wu JC, Mui LM, Cheung CM, Chan Y, Sung JJ. Obesity is associated with increased transient lower esophageal sphincter relaxation. Gastroenterology 2007; 132: 883-889 [PMID: 17324403 DOI: 10.1053/j.gastro.2006.12.032]
8. Ter RB. Gender differences in gastroesophageal reflux disease. J Gend Specif Med 2000; 3: 42-44 [PMID: 11253245]
9. Richter JE, Bradley LA, DeMeester TR, Wu WC. Normal 24-hr ambulatory esophageal pH values. Influence of study center, pH electrode, age, and gender. Dig Dis Sci 1992; 37: 849-856 [PMID: 1587189 DOI: 10.1007/BF01300382]
10. Close H, Mason JM, Wilson D, Hungin AP. Hormone replacement therapy is associated with gastro-oesophageal reflux disease: a retrospective cohort study. BMC Gastroenterol 2012; 12: 56 [PMID: 22642788 DOI: 10.1186/1471-230X-12-56]
11. Zheng Z, Margolis KL, Liu S, Tinker LF, Ye W. Effects of estrogen with and without progestin and obesity on symptomatic gastroesophageal reflux. Gastroenterology 2008; 135: 72-81 [PMID: 18502208 DOI: 10.1053/j.gastro.2008.03.039.Effects]
12. Menon S, Prew S, Parkes G, Evans S, Smith L, Nightingale P, Trudgill N. Do differences in female sex hormone levels contribute to gastro-oesophageal reflux disease? Eur J Gastroenterol Hepatol 2013; 25: 772-777 [PMID: 23470358 DOI: 10.1097/MEG.0b013e32835fbaab]
13. Corley DA, Kubo A, Zhao W. Abdominal obesity, ethnicity and gastro-oesophageal reflux symptoms. Gut 2007; 56: 756-762 [PMID: 17047097 DOI: 10.1136/gut.2006.109413]
14. Stark R, Ashley SE, Andrews ZB. AMPK and the neuroendocrine regulation of appetite and energy expenditure. Mol Cell Endocrinol 2013; 366: 215-223 [PMID: 22789749 DOI: 10.1016/j.mce.2012.06.012]
15. Myers MG, Cowley MA, Münzberg H. Mechanisms of leptin action and leptin resistance. Annu Rev Physiol 2008; 70: 537-556 [PMID: 17937601 DOI: 10.1146/annurev. physiol.70.113006.100707]
16. Nahata M, Saegusa Y, Harada Y, Tsuchiya N, Hattori T, Takeda H. Changes in ghrelin-related factors in gastroesophageal reflux disease in rats. Gastroenterol Res Pract 2013; 2013: 504816 [PMID: 23653638 DOI: 10.1155/2013/504816]
17. Rubenstein JH, Morgenstern H, McConell D, Scheiman JM, Schoenfeld P, Appelman H, McMahon LF, Kao JY, Metko V, Zhang M, Inadomi JM. Associations of diabetes mellitus, insulin, leptin, and ghrelin with gastroesophageal reflux and Barrett’s esophagus. Gastroenterology 2013; 145: 1237-1244.e1-5 [PMID: 23999171 DOI: 10.1053/j.gastro.2013.08.052]
18. Abdelkader NA, Montasser IF, Bioumy EE, Saad WE. Impact of anthropometric measures and serum leptin on severity of gastroesophageal reflux disease. Dis Esophagus 2015; 28: 691-698 [PMID: 25168182 DOI: 10.1111/dote.12271]
19. Kato M, Watabe K, Hamasaki T, Umeda M, Furubayashi A, Kinoshita K, Kishida O, Fujimoto T, Yamada A, Tsukamoto Y, Yamamoto S, Kamada Y, Yoshida Y, Kiso S, Tsutsui S, Kihara S, Hayashi N, Matsuzawa Y. Association of low serum adiponectin levels with erosive esophagitis in men: an analysis of 2405 subjects undergoing physical check-ups. J Gastroenterol 2011; 46: 1361-1367 [PMID: 21845377 DOI: 10.1007/s00535-011-0453-3]
20. Catanzaro R, Calabrese F, Occhipinti S, Anzalone MG, Italia A, Milazzo M, Marotta F. Nonalcoholic fatty liver disease increases risk for gastroesophageal reflux symptoms. Dig Dis Sci 2014; 59: 1939-1945 [PMID: 24718860 DOI: 10.1007/s10620-014-3113-7]
21. Tarantino G, Finelli C. What about non-alcoholic fatty liver disease as a new criterion to define metabolic syndrome? World J Gastroenterol 2013; 19: 3375-3384 [PMID: 23801829 DOI: 10.3748/wjg.v19.i22.3375]
22. Sonnenberg A. Effects of environment and lifestyle on gastroesophageal reflux disease. Dig Dis 2011; 29: 229-234 [PMID: 21734389 DOI: 10.1159/000323927]
23. Singh M, Lee J, Gupta N, Gaddam S, Smith BK, Wani SB, Sullivan DK, Rastogi A, Bansal A, Donnelly JE, Sharma P. Weight loss can lead to resolution of gastroesophageal reflux disease symptoms: a prospective intervention trial. Obesity (Silver Spring) 2013; 21: 284-290 [PMID: 23532991 DOI: 10.1038/oby.2012.180] 24 Fraser-Moodie CA, Norton B, Gornall C, Magnago S, Weale AR, Holmes GK. Weight loss has an independent beneficial effect on symptoms of gastro-oesophageal reflux in patients who are overweight. Scand J Gastroenterol 1999; 34: 337-340 [PMID: 10365891 DOI: 10.1080/003655299750026326]
24. Eherer A. Management of gastroesophageal reflux disease: lifestyle modification and alternative approaches. Dig Dis 2014; 32: 149-151 [PMID: 24603400 DOI: 10.1159/000357181]
25. Nocon M, Labenz J, Willich SN. Lifestyle factors and symptoms of gastro-oesophageal reflux - a population-based study. Aliment Pharmacol Ther 2006; 23: 169-174 [PMID: 16393294 DOI: 10.1111/j.1365-2036.2006.02727.x]
26. El-Serag HB, Satia JA, Rabeneck L. Dietary intake and the risk of gastro-oesophageal reflux disease: a cross sectional study in volunteers. Gut 2005; 54: 11-17 [PMID: 15591498 DOI: 10.1136/gut.2004.040337]
27. Wendl B, Pfeiffer A, Pehl C, Schmidt T, Kaess H. Effect of decaffeination of coffee or tea on gastro-oesophageal reflux. Aliment Pharmacol Ther 1994; 8: 283-287 [PMID: 7918922 DOI: 10.1111/j.1365-2036.1994.tb00289.x]
28. Thomas FB, Steinbaugh JT, Fromkes JJ, Mekhjian HS, Caldwell JH. Inhibitory effect of coffee on lower esophageal sphincter pressure. Gastroenterology 1980; 79: 1262-1266 [PMID: 7002705]
29. Cohen S, Booth GH. Gastric acid secretion and lower-esophageal-sphincter pressure in response to coffee and caffeine. N Engl J Med 1975; 293: 897-899 [PMID: 1177987 DOI: 10.1056/NEJM197510302931803]
30. Nebel OT, Castell DO. Lower esophageal sphincter pressure changes after food ingestion. Gastroenterology 1972; 63: 778-783 [PMID: 5079488]
31. McDougall NI, Johnston BT, Collins JS, McFarland RJ, Love AH. Three- to 4.5-year prospective study of prognostic indicators in gastro-oesophageal reflux disease. Scand J Gastroenterol 1998; 33: 1016-1022 [PMID: 9829353 DOI: 10.1080/003655298750026688]
32. Sharma P, Vakil N, Monyak JT, Silberg DG. Obesity does not affect treatment outcomes with proton pump inhibitors. J Clin Gastroenterol 2013; 47: 672-677 [PMID: 23442835 DOI: 10.1097/MCG.0b013e31827e46be]
33. Chen WY, Chang WL, Tsai YC, Cheng HC, Lu CC, Sheu BS. Double-dosed pantoprazole accelerates the sustained symptomatic response in overweight and obese patients with reflux esophagitis in Los Angeles grades A and B. Am J Gastroenterol 2010; 105: 1046-1052 [PMID: 19904250 DOI: 10.1038/ajg.2009.632]
34. Bruley des Varannes S, Coudsy B, Waechter S, Delemos B, Xiang J, Lococo J, Ducrotté P. On-demand proton pump inhibitory treatment in overweight/obese patients with gastroesophageal reflux disease: are there pharmacodynamic arguments for using higher doses? Digestion 2013; 88: 56-63 [PMID: 23880545 DOI: 10.1159/000351389]
35. Becker V, Grotz S, Schlag C, Nennstiel S, Beitz A, Haller B, Schmid RM, Meining A, Bajbouj M. Positive predictors for gastroesophageal reflux disease and the therapeutic response to proton-pump inhibitors. World J Gastroenterol 2014; 20: 4017-4024 [PMID: 24744591 DOI: 10.3748/wjg.v20.i14.4017]
36. Minjarez RC, Jobe BA. Surgical therapy for gastroesophageal reflux disease. GI Motil online 2006; 8: 1-36 [DOI: 10.1038/gimo56]
37. Stefanidis D, Hope WW, Kohn GP, Reardon PR, Richardson WS, Fanelli RD. Guidelines for surgical treatment of gastroesophageal reflux disease. Surg Endosc 2010; 24: 2647-2669 [PMID: 20725747 DOI: 10.1007/s00464-010-1267-8]
38. Anvari M, Allen C. Five-year comprehensive outcomes evaluation in 181 patients after laparoscopic Nissen fundoplication. J Am Coll Surg 2003; 196: 51-57; discussion 57-58; author reply 58-59 [PMID: 12517549 DOI: 10.1016/S1072-7515(02)01604-6]
39. Bloomston M, Nields W, Rosemurgy AS. Symptoms and antireflux medication use following laparoscopic Nissen fundoplication: outcome at 1 and 4 years. JSLS 2003; 7: 211-218 [PMID: 14558708]
40. Perez AR, Moncure AC, Rattner DW. Obesity adversely affects the outcome of antireflux operations. Surg Endosc 2001; 15: 986-989 [PMID: 11443428 DOI: 10.1007/s004640000392]
41. Tekin K, Toydemir T, Yerdel MA. Is laparoscopic antireflux surgery safe and effective in obese patients? Surg Endosc 2012; 26: 86-95 [PMID: 21863377 DOI: 10.1007/s00464-011-1832-9]
42. Fraser J, Watson DI, O’Boyle CJ, Jamieson GG. Obesity and its effect on outcome of laparoscopic Nissen fundoplication. Dis Esophagus 2001; 14: 50-53 [PMID: 11422306 DOI: 10.1046/j.1442-2050.2001.00157.x]
43. Winslow ER, Frisella MM, Soper NJ, Klingensmith ME. Obesity does not adversely affect the outcome of laparoscopic antireflux surgery (LARS). Surg Endosc 2003; 17: 2003-2011 [PMID: 14577029 DOI: 10.1007/s00464-003-8118-9]
44. Campos GM, Peters JH, DeMeester TR, Oberg S, Crookes PF, Tan S, DeMeester SR, Hagen JA, Bremner CG. Multivariate analysis of factors predicting outcome after laparoscopic Nissen fundoplication. J Gastrointest Surg 1999; 3: 292-300 [PMID: 10481122]
45. D’Alessio MJ, Arnaoutakis D, Giarelli N, Villadolid DV, Rosemurgy AS. Obesity is not a contraindication to laparoscopic Nissen fundoplication. J Gastrointest Surg 2005; 9: 949-954 [PMID: 16137590 DOI: 10.1016/j.gassur.2005.04.019]
46. Luketina RR, Koch OO, Köhler G, Antoniou SA, Emmanuel K, Pointner R. Obesity does not affect the outcome of laparoscopic antireflux surgery. Surg Endosc 2015; 29: 1327-1333 [PMID: 25294529 DOI: 10.1007/s00464-014-3842-x]
47. Anvari M, Bamehriz F. Outcome of laparoscopic Nissen fundoplication in patients with body mass index & gt; or=35. Surg Endosc 2006; 20: 230-234 [PMID: 16341568 DOI: 10.1007/s00464-005-0031-y]
48. Morgenthal CB, Lin E, Shane MD, Hunter JG, Smith CD. Who will fail laparoscopic Nissen fundoplication? Preoperative prediction of long-term outcomes. Surg Endosc 2007; 21: 1978-1984 [PMID: 17623236 DOI: 10.1007/s00464-007-9490-7]
49. Soper NJ, Dunnegan D. Anatomic fundoplication failure after laparoscopic antireflux surgery. Ann Surg 1999; 229: 669-676; discussion 676-677 [PMID: 10235525 DOI: 10.1097/00000658-19 9905000-00009]
50. Hahnloser D, Schumacher M, Cavin R, Cosendey B, Petropoulos P. Risk factors for complications of laparoscopic Nissen fundoplication. Surg Endosc 2002; 16: 43-47 [PMID: 11961603 DOI: 10.1007/s004640090119]
51. Witteman BP, Conchillo JM, Rinsma NF, Betzel B, Peeters A, Koek GH, Stassen LP, Bouvy ND. Randomized controlled trial of transoral incisionless fundoplication vs. proton pump inhibitors for treatment of gastroesophageal reflux disease. Am J Gastroenterol 2015; 110: 531-542 [PMID: 25823768 DOI: 10.1038/ajg.2015.28]
52. Testoni PA, Testoni S, Mazzoleni G, Vailati C, Passaretti S. Long-term efficacy of transoral incisionless fundoplication with Esophyx (Tif 2.0) and factors affecting outcomes in GERD patients followed for up to 6 years: a prospective single-center study. Surg Endosc 2015; 29: 2770-2780 [PMID: 25480624 DOI: 10.1007/s00464-014-4008-6]
53. Baltasar A, Serra C, Pérez N, Bou R, Bengochea M, Ferri L. Laparoscopic sleeve gastrectomy: a multi-purpose bariatric operation. Obes Surg 2005; 15: 1124-1128 [PMID: 16197783 DOI: 10.1381/0960892055002248]
54. Brethauer SA, Hammel JP, Schauer PR. Systematic review of sleeve gastrectomy as staging and primary bariatric procedure. Surg Obes Relat Dis 2009; 5: 469-475 [PMID: 19632646 DOI: 10.1016/j.soard.2009.05.011]
55. DuPree CE, Blair K, Steele SR, Martin MJ. Laparoscopic sleeve gastrectomy in patients with preexisting gastroesophageal reflux disease: a national analysis. JAMA Surg 2014; 149: 328-334 [PMID: 24500799 DOI: 10.1001/jamasurg.2013.4323]
56. Tai CM, Huang CK, Lee YC, Chang CY, Lee CT, Lin JT. Increase in gastroesophageal reflux disease symptoms and erosive esophagitis 1 year after laparoscopic sleeve gastrectomy among obese adults. Surg Endosc 2013; 27: 1260-1266 [PMID: 23232995 DOI: 10.1007/s00464-012-2593-9]
57. Howard DD, Caban AM, Cendan JC, Ben-David K. Gastroesophageal reflux after sleeve gastrectomy in morbidly obese patients. Surg Obes Relat Dis 2011; 7: 709-713 [PMID: 21955743]
58. Burgerhart JS, Schotborgh CA, Schoon EJ, Smulders JF, van de Meeberg PC, Siersema PD, Smout AJ. Effect of sleeve gastrectomy on gastroesophageal reflux. Obes Surg 2014; 24: 1436-1441 [PMID: 24619293 DOI: 10.1007/s11695-014-1222-1]
59. Gorodner V, Buxhoeveden R, Clemente G, Solé L, Caro L, Grigaites A. Does laparoscopic sleeve gastrectomy have any influence on gastroesophageal reflux disease? Preliminary results. Surg Endosc 2015; 29: 1760-1768 [PMID: 25303918 DOI: 10.1007/s00464-014-3902-2]
60. Melissas J, Leventi A, Klinaki I, Perisinakis K, Koukouraki S, de Bree E, Karkavitsas N. Alterations of global gastrointestinal motility after sleeve gastrectomy: a prospective study. Ann Surg 2013; 258: 976-982 [PMID: 23160151 DOI: 10.1097/SLA.0b013e3182774522]
61. Melissas J, Daskalakis M, Koukouraki S, Askoxylakis I, Metaxari M, Dimitriadis E, Stathaki M, Papadakis JA. Sleeve gastrectomy-a “food limiting” operation. Obes Surg 2008; 18: 1251-1256 [PMID: 18663545 DOI: 10.1007/s11695-008-9634-4]
62. Chopra A, Chao E, Etkin Y, Merklinger L, Lieb J, Delany H. Laparoscopic sleeve gastrectomy for obesity: can it be considered a definitive procedure? Surg Endosc 2012; 26: 831-837 [PMID: 22179438 DOI: 10.1007/s00464-011-1960-2]
63. Rawlins L, Rawlins MP, Brown CC, Schumacher DL. Sleeve gastrectomy: 5-year outcomes of a single institution. Surg Obes Relat Dis 2013; 9: 21-25 [PMID: 23201209 DOI: 10.1016/j.soard.2012.08.014]
64. Himpens J, Dapri G, Cadière GB. A prospective randomized study between laparoscopic gastric banding and laparoscopic isolated sleeve gastrectomy: results after 1 and 3 years. Obes Surg 2006; 16: 1450-1456 [PMID: 17132410 DOI: 10.1381/09608920677886 9933]
65. Himpens J, Dobbeleir J, Peeters G. Long-term results of laparoscopic sleeve gastrectomy for obesity. Ann Surg 2010; 252: 319-324 [PMID: 20622654 DOI: 10.1097/SLA.0b013e3181e90b31]
66. Braghetto I, Lanzarini E, Korn O, Valladares H, Molina JC, Henriquez A. Manometric changes of the lower esophageal sphincter after sleeve gastrectomy in obese patients. Obes Surg 2010; 20: 357-362 [PMID: 20013071 DOI: 10.1007/s11695-009-0040-3]
67. Hayat JO, Wan A. The effects of sleeve gastectomy on gastroesophageal reflux and gastro-esophageal motility. Expert Rev Gastroenterol Hepatol 2014; 8: 445-452 [PMID: 24580041 DOI: 10.1586/17474124.2014.888951]
68. Baumann T, Grueneberger J, Pache G, Kuesters S, Marjanovic G, Kulemann B, Holzner P, Karcz-Socha I, Suesslin D, Hopt UT, Langer M, Karcz WK. Three-dimensional stomach analysis with computed tomography after laparoscopic sleeve gastrectomy: sleeve dilation and thoracic migration. Surg Endosc 2011; 25: 2323-2329 [PMID: 21298527 DOI: 10.1007/s00464-010-1558-0]
69. Laffin M, Chau J, Gill RS, Birch DW, Karmali S. Sleeve gastrectomy and gastroesophageal reflux disease. J Obes 2013; 2013: 741097 [PMID: 23956846 DOI: 10.1155/2013/741097]
70. Keidar A, Appelbaum L, Schweiger C, Elazary R, Baltasar A. Dilated upper sleeve can be associated with severe postoperative gastroesophageal dysmotility and reflux. Obes Surg 2010; 20: 140-147 [PMID: 19949885 DOI: 10.1007/s11695-009-0032-3]
71. Chang SH, Stoll CR, Song J, Varela JE, Eagon CJ, Colditz GA. The effectiveness and risks of bariatric surgery: an updated systematic review and meta-analysis, 2003-2012. JAMA Surg 2014; 149: 275-287 [PMID: 24352617 DOI: 10.1001/jamasurg.2013.3654]
72. Carlin AM, Zeni TM, English WJ, Hawasli AA, Genaw JA, Krause KR, Schram JL, Kole KL, Finks JF, Birkmeyer JD, Share D, Birkmeyer NJ. The comparative effectiveness of sleeve gastrectomy, gastric bypass, and adjustable gastric banding procedures for the treatment of morbid obesity. Ann Surg 2013; 257: 791-797 [PMID: 23470577]
73. Rohof WO, Bisschops R, Tack J, Boeckxstaens GE. Postoperative problems 2011: fundoplication and obesity surgery. Gastroenterol Clin North Am 2011; 40: 809-821 [PMID: 22100119 DOI: 10.1016/j.gtc.2011.09.002]
74. Belachew M, Legrand M, Vincenti V, Deffechereux T, Jourdan JL, Monami B, Jacquet N. Laparoscopic Placement of Adjustable Silicone Gastric Band in the Treatment of Morbid Obesity: How to Do It. Obes Surg 1995; 5: 66-70 [PMID: 10733796 DOI: 10.1381/096089295765558196]
75. Woodman G, Cywes R, Billy H, Montgomery K, Cornell C, Okerson T. Effect of adjustable gastric banding on changes in gastroesophageal reflux disease (GERD) and quality of life. Curr Med Res Opin 2012; 28: 581-589 [PMID: 22356120 DOI: 10.1185/03007995.2012.666962]
76. Dixon JB, O’Brien PE. Gastroesophageal reflux in obesity: the effect of lap-band placement. Obes Surg 1999; 9: 527-531 [PMID: 10638476 DOI: 10.1381/096089299765552602]
77. Pilone V, Vitiello A, Hasani A, Di Micco R, Monda A, Izzo G, Forestieri P. Laparoscopic adjustable gastric banding outcomes in patients with gastroesophageal reflux disease or hiatal hernia. Obes Surg 2015; 25: 290-294 [PMID: 25030091 DOI: 10.1007/s11695-014-1366-z]
78. Tolonen P, Victorzon M, Niemi R, Mäkelä J. Does gastric banding for morbid obesity reduce or increase gastroesophageal reflux? Obes Surg 2006; 16: 1469-1474 [PMID: 17132413 DOI: 10.1381/096089206778870120]
79. de Jong JR, van Ramshorst B, Timmer R, Gooszen HG, Smout AJ. The influence of laparoscopic adjustable gastric banding on gastroesophageal reflux. Obes Surg 2004; 14: 399-406 [PMID: 15072663 DOI: 10.1381/096089204322917945]
80. Gutschow CA, Collet P, Prenzel K, Hölscher AH, Schneider PM. Long-term results and gastroesophageal reflux in a series of laparoscopic adjustable gastric banding. J Gastrointest Surg 2005; 9: 941-948 [PMID: 16137589 DOI: 10.1016/j.gassur.2005.02.001]
81. Milone L, Daud A, Durak E, Olivero-Rivera L, Schrope B, Inabnet WB, Davis D, Bessler M. Esophageal dilation after laparoscopic adjustable gastric banding. Surg Endosc 2008; 22: 1482-1486 [PMID: 18027041 DOI: 10.1007/s00464-007-9651-8]
82. Naef M, Mouton WG, Naef U, van der Weg B, Maddern GJ, Wagner HE. Esophageal dysmotility disorders after laparoscopic gastric banding-an underestimated complication. Ann Surg 2011; 253: 285-290 [PMID: 21169806 DOI: 10.1097/SLA.0b013e318206843e]
83. Klaus A, Gruber I, Wetscher G, Nehoda H, Aigner F, Peer R, Margreiter R, Weiss H. Prevalent esophageal body motility disorders underlie aggravation of GERD symptoms in morbidly obese patients following adjustable gastric banding. Arch Surg 2006; 141: 247-251 [PMID: 16549689 DOI: 10.1001/archsurg.141.3.247]
84. Khan A, Ren-Fielding C, Traube M. Potentially reversible pseudoachalasia after laparoscopic adjustable gastric banding. J Clin Gastroenterol 2011; 45: 775-779 [PMID: 21778895 DOI: 10.1097/MCG.0b013e318226ae14]
85. Gustavsson S, Westling A. Laparoscopic adjustable gastric banding: complications and side effects responsible for the poor long-term outcome. Semin Laparosc Surg 2002; 9: 115-124 [PMID: 12152154 DOI: 10.1053/slas.2002.126328]
86. Ovrebø KK, Hatlebakk JG, Viste A, Bassøe HH, Svanes K. Gastroesophageal reflux in morbidly obese patients treated with gastric banding or vertical banded gastroplasty. Ann Surg 1998; 228: 51-58 [PMID: 9671066 DOI: 10.1097/00000658-199807000-00008]
87. Angrisani L, Santonicola A, Iovino P, Formisano G, Buchwald H, Scopinaro N. Bariatric Surgery Worldwide 2013. Obes Surg 2015; 25: 1822-1832 [PMID: 25835983 DOI: 10.1007/s11695-015-1657-z]
88. Elder KA, Wolfe BM. Bariatric surgery: a review of procedures and outcomes. Gastroenterology 2007; 132: 2253-2271 [PMID: 17498516 DOI: 10.1053/j.gastro.2007.03.057]
89. Mejía-Rivas MA, Herrera-López A, Hernández-Calleros J, Herrera MF, Valdovinos MA. Gastroesophageal reflux disease in morbid obesity: the effect of Roux-en-Y gastric bypass. Obes Surg 2008; 18: 1217-1224 [PMID: 18512110 DOI: 10.1007/s11695-008-9474-2]
90. Nelson LG, Gonzalez R, Haines K, Gallagher SF, Murr MM. Amelioration of gastroesophageal reflux symptoms following Roux-en-Y gastric bypass for clinically significant obesity. Am Surg 2005; 71: 950-953; discussion 950-953; 953-954 [PMID: 16372614]
91. Ortega J, Escudero MD, Mora F, Sala C, Flor B, Martinez-Valls J, Sanchiz V, Martinez-Alzamora N, Benages A, Lledo S. Outcome of esophageal function and 24-hour esophageal pH monitoring after vertical banded gastroplasty and Roux-en-Y gastric bypass. Obes Surg 2004; 14: 1086-1094 [PMID: 15479598 DOI: 10.1381/0960892041975497]
92. Schauer PR, Ikramuddin S, Gourash W, Ramanathan R, Luketich J. Outcomes after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Ann Surg 2000; 232: 515-529 [PMID: 10998650 DOI: 10.1097/00000658-200010000-00007]
93. Madalosso CA, Gurski RR, Callegari-Jacques SM, Navarini D, Mazzini G, Pereira Mda S. The Impact of Gastric Bypass on Gastroesophageal Reflux Disease in Morbidly Obese Patients. Ann Surg 2016; 263: 110-116 [PMID: 25607766 DOI: 10.1097/SLA.0b013e3181bdff20]
94. Frezza EE, Ikramuddin S, Gourash W, Rakitt T, Kingston A, Luketich J, Schauer P. Symptomatic improvement in gastroesophageal reflux disease (GERD) following laparoscopic Roux-en-Y gastric bypass. Surg Endosc 2002; 16: 1027-1031 [PMID: 11984683 DOI: 10.1007/s00464-001-8313-5]
95. Smith CD, Herkes SB, Behrns KE, Fairbanks VF, Kelly KA, Sarr MG. Gastric acid secretion and vitamin B12 absorption after vertical Roux-en-Y gastric bypass for morbid obesity. Ann Surg 1993; 218: 91-96 [PMID: 8328834]
96. Kourkoulos M, Giorgakis E, Kokkinos C, Mavromatis T, Griniatsos J, Nikiteas N, Tsigris C. Laparoscopic gastric plication for the treatment of morbid obesity: a review. Minim Invasive Surg 2012; 2012: 696348 [PMID: 22811900 DOI: 10.1155/2012/696348]
97. Talebpour M, Amoli BS. Laparoscopic total gastric vertical plication in morbid obesity. J Laparoendosc Adv Surg Tech A 2007; 17: 793-798 [PMID: 18158812 DOI: 10.1089/lap.2006.0128]
98. Tolone S, Cristiano S, Savarino E, Lucido FS, Fico DI, Docimo L . Effects of omega-loop bypass on esophagogastric junction function. Surg Obes Relat Dis 2015; Epub ahead of print [PMID: 25979206 DOI: 10.1016/j.soard.2015.03.011]
99. Fedenko V, Evdoshenko V. Antireflux sleeve gastroplasty: description of a novel technique. Obes Surg 2007; 17: 820-824 [PMID: 17879584 DOI: 10.1007/s11695-007-9124-0]
100. Lee WJ, Han ML, Ser KH, Tsou JJ, Chen JC, Lin CH. Laparoscopic Nissen fundoplication with gastric plication as a potential treatment of morbidly obese patients with GERD, first experience and results. Obes Surg 2014; 24: 1447-1452 [PMID: 24610517 DOI: 10.1007/s11695-014-1223-0]
101. Khazzaka A, Sarkis R. Fundoplication combined with mediogastric plication. Surg Obes Relat Dis 2013; 9: 398-403 [PMID: 21978753 DOI: 10.1016/j.soard.2011.08.019]
102. Swidnicka-Siergiejko A, Wróblewski E, Andrzej D. Endoscopic treatment of obesity. Can J Gastroenterol 2011; 25: 627-633 [PMID: 22059171]
103. Devière J, Ojeda Valdes G, Cuevas Herrera L, Closset J, Le Moine O, Eisendrath P, Moreno C, Dugardeyn S, Barea M, de la Torre R, Edmundowicz S, Scott S. Safety, feasibility and weight loss after transoral gastroplasty: First human multicenter study. Surg Endosc 2008; 22: 589-598 [PMID: 17973163 DOI: 10.1007/s00464-007-9662-5]
104. Moreno C, Closset J, Dugardeyn S, Baréa M, Mehdi A, Collignon L, Zalcman M, Baurain M, Le Moine O, Devière J. Transoral gastroplasty is safe, feasible, and induces significant weight loss in morbidly obese patients: results of the second human pilot study. Endoscopy 2008; 40: 406-413 [PMID: 18459077 DOI: 10.1055/s-2007-995748]
105. Legner A, Altorjay A, Juhasz A, Stadlhuber R, Reich V, Hunt B, Rothstein R, Filipi C. Transoral mucosal excision sutured gastroplasty: a pilot study for GERD and obesity with two-year follow-up. Surg Innov 2014; 21: 456-463 [PMID: 24623807 DOI: 10.1177/1553350613508228]
106. Abu Dayyeh BK, Rajan E, Gostout CJ. Endoscopic sleeve gastroplasty: a potential endoscopic alternative to surgical sleeve gastrectomy for treatment of obesity. Gastrointest Endosc 2013; 78: 530-535 [PMID: 23711556 DOI: 10.1016/j.gie.2013.04.197]
107. Brethauer SA, Chand B, Schauer PR, Thompson CC. Transoral gastric volume reduction as intervention for weight management: 12-month follow-up of TRIM trial. Surg Obes Relat Dis 2012; 8: 296-303 [PMID: 22178565 DOI: 10.1016/j.soard.2011.10.016]
108. Familiari P, Costamagna G, Bléro D, Le Moine O, Perri V, Boskoski I, Coppens E, Barea M, Iaconelli A, Mingrone G, Moreno C, Devière J. Transoral gastroplasty for morbid obesity: a multicenter trial with a 1-year outcome. Gastrointest Endosc 2011; 74: 1248-1258 [PMID: 22136774 DOI: 10.1016/j.gie.2011.08.046]
109. Lopez-Nava G, Galvão MP, da Bautista-Castaño I, Jimenez A, De Grado T, Fernandez-Corbelle JP. Endoscopic sleeve gastroplasty for the treatment of obesity. Endoscopy 2015; 47: 449-452 [PMID: 25380508]
110. Fogel R, De Fogel J, Bonilla Y, De La Fuente R. Clinical experience of transoral suturing for an endoluminal vertical gastroplasty: 1-year follow-up in 64 patients. Gastrointest Endosc 2008; 68: 51-58 [PMID: 18355825 DOI: 10.1016/j.gie.2007.10.061]
111. Nanni G, Familiari P, Mor A, Iaconelli A, Perri V, Rubino F, Boldrini G, Salerno MP, Leccesi L, Iesari S, Sollazzi L, Perilli V, Castagneto M, Mingrone G, Costamagna G. Effectiveness of the Transoral Endoscopic Vertical Gastroplasty (TOGa®): a good balance between weight loss and complications, if compared with gastric bypass and biliopancreatic diversion. Obes Surg 2012; 22: 1897-1902 [PMID: 23001571 DOI: 10.1007/s11695-012-0770-5]
112. Mathus-Vliegen EM, Tygat GN. Gastro-oesophageal reflux in obese subjects: influence of overweight, weight loss and chronic gastric balloon distension. Scand J Gastroenterol 2002; 37: 1246-1252 [PMID: 12465720 DOI: 10.1080/00365520276102049 8]
113. Rossi A, Bersani G, Ricci G, Petrini C, DeFabritiis G, Alvisi V. Intragastric balloon insertion increases the frequency of erosive esophagitis in obese patients. Obes Surg 2007; 17: 1346-1349 [PMID: 18000724 DOI: 10.1007/s11695-007-9239-3]
114. Hirsch DP, Mathus-Vliegen EM, Dagli U, Tytgat GN, Boeckxstaens GE. Effect of prolonged gastric distention on lower esophageal sphincter function and gastroesophageal reflux. Am J Gastroenterol 2003; 98: 1696-1704 [PMID: 12907321 DOI: 10.1111/j.1572-0241.2003.07588.x]
115. Bang CS, Baik GH, Shin IS, Kim JB, Suk KT, Yoon JH, Kim YS, Kim DJ. Effect of intragastric injection of botulinum toxin A for the treatment of obesity: a meta-analysis and meta-regression. Gastrointest Endosc 2015; 81: 1141-1149.e1-7 [PMID: 25765772 DOI: 10.1016/j.gie.2014.12.025]
116. Foschi D, Lazzaroni M, Sangaletti O, Corsi F, Trabucchi E, Bianchi Porro G. Effects of intramural administration of Botulinum Toxin A on gastric emptying and eating capacity in obese patients. Dig Liver Dis 2008; 40: 667-672 [PMID: 18420471 DOI: 10.1016/j.dld.2008.02.040]
117. Sandler BJ, Rumbaut R, Swain CP, Torres G, Morales L, Gonzales L, Schultz S, Talamini MA, Jacobsen GR, Horgan S. One-year human experience with a novel endoluminal, endoscopic gastric bypass sleeve for morbid obesity. Surg Endosc 2015; 29: 3298-3303 [PMID: 25631114 DOI: 10.1007/s00464-015-4081-5]